12,569 research outputs found
Network-based stratification of tumor mutations.
Many forms of cancer have multiple subtypes with different causes and clinical outcomes. Somatic tumor genome sequences provide a rich new source of data for uncovering these subtypes but have proven difficult to compare, as two tumors rarely share the same mutations. Here we introduce network-based stratification (NBS), a method to integrate somatic tumor genomes with gene networks. This approach allows for stratification of cancer into informative subtypes by clustering together patients with mutations in similar network regions. We demonstrate NBS in ovarian, uterine and lung cancer cohorts from The Cancer Genome Atlas. For each tissue, NBS identifies subtypes that are predictive of clinical outcomes such as patient survival, response to therapy or tumor histology. We identify network regions characteristic of each subtype and show how mutation-derived subtypes can be used to train an mRNA expression signature, which provides similar information in the absence of DNA sequence
Sparse integrative clustering of multiple omics data sets
High resolution microarrays and second-generation sequencing platforms are
powerful tools to investigate genome-wide alterations in DNA copy number,
methylation and gene expression associated with a disease. An integrated
genomic profiling approach measures multiple omics data types simultaneously in
the same set of biological samples. Such approach renders an integrated data
resolution that would not be available with any single data type. In this
study, we use penalized latent variable regression methods for joint modeling
of multiple omics data types to identify common latent variables that can be
used to cluster patient samples into biologically and clinically relevant
disease subtypes. We consider lasso [J. Roy. Statist. Soc. Ser. B 58 (1996)
267-288], elastic net [J. R. Stat. Soc. Ser. B Stat. Methodol. 67 (2005)
301-320] and fused lasso [J. R. Stat. Soc. Ser. B Stat. Methodol. 67 (2005)
91-108] methods to induce sparsity in the coefficient vectors, revealing
important genomic features that have significant contributions to the latent
variables. An iterative ridge regression is used to compute the sparse
coefficient vectors. In model selection, a uniform design [Monographs on
Statistics and Applied Probability (1994) Chapman & Hall] is used to seek
"experimental" points that scattered uniformly across the search domain for
efficient sampling of tuning parameter combinations. We compared our method to
sparse singular value decomposition (SVD) and penalized Gaussian mixture model
(GMM) using both real and simulated data sets. The proposed method is applied
to integrate genomic, epigenomic and transcriptomic data for subtype analysis
in breast and lung cancer data sets.Comment: Published in at http://dx.doi.org/10.1214/12-AOAS578 the Annals of
Applied Statistics (http://www.imstat.org/aoas/) by the Institute of
Mathematical Statistics (http://www.imstat.org
Change-point model on nonhomogeneous Poisson processes with application in copy number profiling by next-generation DNA sequencing
We propose a flexible change-point model for inhomogeneous Poisson Processes,
which arise naturally from next-generation DNA sequencing, and derive score and
generalized likelihood statistics for shifts in intensity functions. We
construct a modified Bayesian information criterion (mBIC) to guide model
selection, and point-wise approximate Bayesian confidence intervals for
assessing the confidence in the segmentation. The model is applied to DNA Copy
Number profiling with sequencing data and evaluated on simulated spike-in and
real data sets.Comment: Published in at http://dx.doi.org/10.1214/11-AOAS517 the Annals of
Applied Statistics (http://www.imstat.org/aoas/) by the Institute of
Mathematical Statistics (http://www.imstat.org
Incorporating expression data in metabolic modeling: a case study of lactate dehydrogenase
Integrating biological information from different sources to understand
cellular processes is an important problem in systems biology. We use data from
mRNA expression arrays and chemical kinetics to formulate a metabolic model
relevant to K562 erythroleukemia cells. MAP kinase pathway activation alters
the expression of metabolic enzymes in K562 cells. Our array data show changes
in expression of lactate dehydrogenase (LDH) isoforms after treatment with
phorbol 12-myristate 13-acetate (PMA), which activates MAP kinase signaling. We
model the change in lactate production which occurs when the MAP kinase pathway
is activated, using a non-equilibrium, chemical-kinetic model of homolactic
fermentation. In particular, we examine the role of LDH isoforms, which
catalyze the conversion of pyruvate to lactate. Changes in the isoform ratio
are not the primary determinant of the production of lactate. Rather, the total
concentration of LDH controls the lactate concentration.Comment: In press, Journal of Theoretical Biology. 27 pages, 9 figure
Recommended from our members
Multi-scale cellular engineering: From molecules to organ-on-a-chip.
Recent technological advances in cellular and molecular engineering have provided new insights into biology and enabled the design, manufacturing, and manipulation of complex living systems. Here, we summarize the state of advances at the molecular, cellular, and multi-cellular levels using experimental and computational tools. The areas of focus include intrinsically disordered proteins, synthetic proteins, spatiotemporally dynamic extracellular matrices, organ-on-a-chip approaches, and computational modeling, which all have tremendous potential for advancing fundamental and translational science. Perspectives on the current limitations and future directions are also described, with the goal of stimulating interest to overcome these hurdles using multi-disciplinary approaches
Recommended from our members
A human lung tumor microenvironment interactome identifies clinically relevant cell-type cross-talk.
BackgroundTumors comprise a complex microenvironment of interacting malignant and stromal cell types. Much of our understanding of the tumor microenvironment comes from in vitro studies isolating the interactions between malignant cells and a single stromal cell type, often along a single pathway.ResultTo develop a deeper understanding of the interactions between cells within human lung tumors, we perform RNA-seq profiling of flow-sorted malignant cells, endothelial cells, immune cells, fibroblasts, and bulk cells from freshly resected human primary non-small-cell lung tumors. We map the cell-specific differential expression of prognostically associated secreted factors and cell surface genes, and computationally reconstruct cross-talk between these cell types to generate a novel resource called the Lung Tumor Microenvironment Interactome (LTMI). Using this resource, we identify and validate a prognostically unfavorable influence of Gremlin-1 production by fibroblasts on proliferation of malignant lung adenocarcinoma cells. We also find a prognostically favorable association between infiltration of mast cells and less aggressive tumor cell behavior.ConclusionThese results illustrate the utility of the LTMI as a resource for generating hypotheses concerning tumor-microenvironment interactions that may have prognostic and therapeutic relevance
Translational Oncogenomics and Human Cancer Interactome Networks
An overview of translational, human oncogenomics, transcriptomics and cancer interactomic networks is presented together with basic concepts and potential, new applications to Oncology and Integrative Cancer Biology. Novel translational oncogenomics research is rapidly expanding through the application of advanced technology, research findings and computational tools/models to both pharmaceutical and clinical problems. A self-contained presentation is adopted that covers both fundamental concepts and the most recent biomedical, as well as clinical, applications. Sample analyses in recent clinical studies have shown that gene expression data can be employed to distinguish between tumor types as well as to predict outcomes. Potentially important applications of such results are individualized human cancer therapies or, in general, ‘personalized medicine’. Several cancer detection techniques are currently under development both in the direction of improved detection sensitivity and increased time resolution of cellular events, with the limits of single molecule detection and picosecond time resolution already reached. The urgency for the complete mapping of a human cancer interactome with the help of such novel, high-efficiency / low-cost and ultra-sensitive techniques is also pointed out
Why one-size-fits-all vaso-modulatory interventions fail to control glioma invasion: in silico insights
There is an ongoing debate on the therapeutic potential of vaso-modulatory
interventions against glioma invasion. Prominent vasculature-targeting
therapies involve functional tumour-associated blood vessel deterioration and
normalisation. The former aims at tumour infarction and nutrient deprivation
medi- ated by vascular targeting agents that induce occlusion/collapse of
tumour blood vessels. In contrast, the therapeutic intention of normalising the
abnormal structure and function of tumour vascular net- works, e.g. via
alleviating stress-induced vaso-occlusion, is to improve chemo-, immuno- and
radiation therapy efficacy. Although both strategies have shown therapeutic
potential, it remains unclear why they often fail to control glioma invasion
into the surrounding healthy brain tissue. To shed light on this issue, we
propose a mathematical model of glioma invasion focusing on the interplay
between the mi- gration/proliferation dichotomy (Go-or-Grow) of glioma cells
and modulations of the functional tumour vasculature. Vaso-modulatory
interventions are modelled by varying the degree of vaso-occlusion. We
discovered the existence of a critical cell proliferation/diffusion ratio that
separates glioma invasion re- sponses to vaso-modulatory interventions into two
distinct regimes. While for tumours, belonging to one regime, vascular
modulations reduce the tumour front speed and increase the infiltration width,
for those in the other regime the invasion speed increases and infiltration
width decreases. We show how these in silico findings can be used to guide
individualised approaches of vaso-modulatory treatment strategies and thereby
improve success rates
- …